Issue 24, 2019, Issue in Progress

A combined experimental and density functional theory study of metformin oxy-cracking for pharmaceutical wastewater treatment

Abstract

Pharmaceutical compounds are emerging contaminants that have been detected in surface water across the world. Because conventional wastewater treatment plants are not designed to treat such pollutants, new technologies are needed to degrade and oxidize such contaminants. The newly developed oxy-cracking process was utilized to treat the antidiabetic drug, metformin. The process, which involved partial oxidation of metformin in alkaline aqueous medium, proved to decompose the drug into small organic molecules, with minimum emission of CO2, therefore, increasing its biodegradability and removal from industrial treatment plants. The reaction gaseous products were probed by online gas chromatography. The liquid phase before and after oxy-cracking was analyzed for total carbon content by TOC and gas chromatography mass spectrometry. The products formed from the nitrogen-rich drug included ammonia, amines, amidines, and urea derivatives. A reaction mechanism for the oxy-cracking process is proposed. Because the hydroxyl radical (˙OH) is believed to play a central role in the oxy-cracking process, the mechanism is initiated by ˙OH attacks on metformin, followed by single decomposition or isomerization steps into stable products. The reactions were investigated using density functional theory calculations and validated using high quality 2nd order Møller–Plesset perturbation theory energy calculations.

Graphical abstract: A combined experimental and density functional theory study of metformin oxy-cracking for pharmaceutical wastewater treatment

Supplementary files

Article information

Article type
Paper
Submitted
04 Mar 2019
Accepted
18 Apr 2019
First published
01 May 2019
This article is Open Access
Creative Commons BY license

RSC Adv., 2019,9, 13403-13413

A combined experimental and density functional theory study of metformin oxy-cracking for pharmaceutical wastewater treatment

I. Badran, A. D. Manasrah and Nashaat N. Nassar, RSC Adv., 2019, 9, 13403 DOI: 10.1039/C9RA01641D

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements